|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Notice to Readers: Update: Penicillin G AvailabilityIn October 1999, the Food and Drug Administration (FDA) and CDC announced a shortage of penicillin G (potassium and sodium) for intravenous injection as a result of decreased production by a major manufacturer (1). In response to the shortage, FDA has identified a temporary alternate supplier of penicillin G sodium, Biochemie GmbH, Kundl, Austria, The company has supplied penicillin G to the United States since December 9, 1999. This product is distributed by Geneva Pharmaceuticals, Inc. (Broomfield, Colorado), and should be available through wholesale suppliers. Because quantities are limited, Geneva Pharmaceuticals is operating under a drug shortage allocation program. For emergency allocations, contact Jenny Whitehouse, Customer Support Supervisor, Geneva Pharmaceuticals, telephone (303) 438-4399; fax (303) 727-4656; e-mail: jenny.whitehouse@gx.novartis.com). Another source of penicillin G potassium in frozen bags is Baxter Corporation (Deerfield, Illinois) at http://www.baxter.com*. If penicillin cannot be obtained, alternative treatment recommendations for some infections can be found at http://www.cdc.gov/nchstp/dstd/penicillinG.htm. CDC requests case reports from physicians about patients with neurosyphilis or congenital syphilis who have been treated with an alternative regimen from September 1, 1999, to February 15, 2000. To report such persons, a form may be downloaded from http://www.cdc.gov/nchstp/dstd/PenGForm.htm, completed, and mailed to CDC's National Center for HIV, STD, and TB Prevention, Corporate Square Boulevard, Atlanta, GA 30329, or may be requested by telephone, (404) 639-8191. Reference
* References to sites of non-CDC organizations on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 1/26/2000 and Human Services. |
|||||||||
This page last reviewed 5/2/01
|